PL
PL · PL · PL-100366353
Xanderla LA
ATC L02AE03
Last synced from URPL (Poland) on
Identification
ManufacturerTeva Pharmaceuticals Polska Sp. z o.o.
CountryPL (PL)
ATC codeL02AE03
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 3
- gtin05909991335595
- gtin05909991335601
- gtin05909991335618
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Implant w ampułko-strzykawce",
"source": "urpl",
"strength": "10,8 mg",
"packaging": "05909991335595 ¦ Rp ¦ 123211\n1 amp.-strzyk. 10,8 mg\n05909991335601 ¦ Rp ¦ 123212\n2 amp.-strzyk. 10,8 mg\n05909991335618 ¦ Rp ¦ 123213\n3 amp.-strzyk. 10,8 mg",
"substance": "Goserelini acetas 12,5 mg/implant",
"common_name": "Goserelinum",
"pl_product_id": "100366353",
"pozwolenie_nr": "24310",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}Related drugs
Other records sharing ATC code L02AE03.
Access this data programmatically
Query Xanderla LA and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.